FindTrial
Sign In

A Study of side effects and quality of life in patients with oral cavity and oropharyngeal cancers undergoing radiotherapy.

A study of oral mucositis, pain, xerostomia and quality of life in patients with oral cavity and oropharyngeal cancers undergoing radiotherapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072273
Enrollment
67
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Control Intervention1: NIL: NIL

Sponsors

Sri Venkateswara Institute of Medical Sciences Tirupati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Carcinoma of head and neck including oral cavity, oropharynx undergoing IMRT, VMAT and concurrent chemotherapy . 2.Patients of age group between 18-65 yrs. 3.Patient with ECOG 0-2. 4.Patients willing to sign an informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with previous history of radiation to head and neck. 2. Patients with known distant metastasis. 3. Patients with ECOG 3-4 4. Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
To assess the toxicities in patients of head and neck cancer undergoing radiotherapy 1) pain, 2) oral mucositis 3) XerostomiaTimepoint: From Day 1 of treatment to 6 months after treatment completion.—

Secondary

MeasureTime frame
To assess the quality of lifeTimepoint: From Day 1 of treatment to 6 months after treatment completion.—

Countries

India

Contacts

Public ContactDr B V Subramanian

Sri Venkateswara Institute of Medical Sciences, Tirupati.

ravibalasubramanian@hotmail.com9849692950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026